Get the Stockscreener App
31.43
1.58%
0.49
Harmony Biosciences Holdings Inc stock is traded at $31.43, with a volume of 860.17K.
It is up +1.58% in the last 24 hours and up +16.19% over the past month.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
See More
Previous Close:
$30.94
Open:
$30.9
24h Volume:
860.17K
Relative Volume:
1.01
Market Cap:
$1.81B
Revenue:
$772.53M
Net Income/Loss:
$180.90M
P/E Ratio:
10.13
EPS:
3.1024
Net Cash Flow:
$258.73M
1W Performance:
+10.01%
1M Performance:
+16.19%
6M Performance:
-6.01%
1Y Performance:
-9.97%
1-Day Range:
$30.55
$32.00
1-Week Range:
$27.66
$32.00
52-Week Range:
$25.52
$40.93
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
Name
Harmony Biosciences Holdings Inc
Sector
Industry
Phone
(484) 539-9800
Address
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
31.43 | 1.78B | 772.53M | 180.90M | 258.73M | 3.1024 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-25 | Initiated | Truist | Buy |
| Jul-10-25 | Resumed | Goldman | Neutral |
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Dec-17-24 | Initiated | H.C. Wainwright | Buy |
| Oct-10-24 | Resumed | Raymond James | Outperform |
| Sep-10-24 | Initiated | UBS | Buy |
| Jun-21-24 | Initiated | Citigroup | Buy |
| Jan-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-25-23 | Downgrade | Goldman | Neutral → Sell |
| Sep-07-23 | Initiated | Berenberg | Buy |
| Apr-20-23 | Initiated | BofA Securities | Neutral |
| Oct-14-22 | Upgrade | Janney | Neutral → Buy |
| Oct-14-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-03-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-13-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-14-22 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-01-21 | Initiated | Oppenheimer | Outperform |
| Nov-04-21 | Initiated | Raymond James | Outperform |
| Sep-23-21 | Initiated | Needham | Buy |
| Mar-29-21 | Upgrade | Goldman | Neutral → Buy |
| Sep-14-20 | Initiated | Goldman | Neutral |
| Sep-14-20 | Initiated | Jefferies | Buy |
| Sep-14-20 | Initiated | Piper Sandler | Overweight |
View All
Harmony Biosciences Holdings Inc Stock (HRMY) Latest News
Using Ichimoku Cloud for Harmony Biosciences Holdings Inc. technicalsQuarterly Trade Report & AI Forecasted Entry and Exit Points - newser.com
(HRMY) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Mizuho Raises Price Target for HRMY, Maintains Outperform Rating - GuruFocus
Why Harmony Biosciences Holdings Inc. stock could benefit from AI revolution2025 Fundamental Recap & Community Driven Trade Alerts - newser.com
Should you hold or exit Harmony Biosciences Holdings Inc. nowJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - newser.com
Forecasting Harmony Biosciences Holdings Inc. price range with options dataWeekly Trend Recap & AI Driven Stock Movement Reports - newser.com
Will Harmony Biosciences Holdings Inc. outperform the marketJuly 2025 Review & Capital Protection Trading Alerts - newser.com
What technical signals suggest for Harmony Biosciences Holdings Inc. stockJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
Will Harmony Biosciences Holdings Inc. stock gain from lower inflation2025 Market Trends & Growth Focused Stock Pick Reports - newser.com
Why Harmony Biosciences Holdings Inc. stock is favored by top institutions2025 Year in Review & Smart Money Movement Tracker - newser.com
What insider trading reveals about Harmony Biosciences Holdings Inc. stockTrade Risk Summary & Weekly High Potential Stock Alerts - newser.com
What Wall Street predicts for Harmony Biosciences Holdings Inc. stock priceMarket Trend Review & Technical Analysis for Trade Confirmation - newser.com
Is Harmony Biosciences Holdings Inc. stock a top momentum playEarnings Miss & Community Verified Trade Signals - newser.com
Will Harmony Biosciences Holdings Inc. stock reach all time highs in 2025 - newser.com
Developing predictive dashboards with Harmony Biosciences Holdings Inc. data2025 Institutional Moves & Community Verified Swing Trade Signals - newser.com
Sector ETF performance correlation with Harmony Biosciences Holdings Inc.2025 Performance Recap & Comprehensive Market Scan Insights - newser.com
Raised Revenue Guidance and Strong Q3 Results Could Be a Game Changer for Harmony Biosciences (HRMY) - Yahoo Finance
Harmony Biosciences (HRMY) Margin Expansion Reinforces Bullish Value Narrative - Yahoo Finance
Harmony Biosciences Holdings Inc (HRMY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ... - Investing.com Canada
Harmony Biosciences (NASDAQ:HRMY) Announces Earnings Results - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2025 Earnings Call Transcript - Insider Monkey
Harmony Biosciences Holdings Inc (HRMY) Q3 2025 Earnings Call Hi - GuruFocus
How interest rate cuts could boost Harmony Biosciences Holdings Inc. stockJuly 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
Harmony Biosciences Holdings (NASDAQ:HRMY) Seems To Use Debt Rather Sparingly - 富途牛牛
Versor Investments LP Takes $600,000 Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Using Python tools to backtest Harmony Biosciences Holdings Inc. strategies - newser.com
Is Sri Ramakrishna Mills Coimbatore Limited on Track for Record Quarterly RevenueStock Buyback Updates & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Harmony Biosciences Holdings Inc Stock Analysis and ForecastMarket Rumors and News & Minimal Capital Trading Plans - earlytimes.in
Decoding Harmony Biosciences Holdings Inc (HRMY): A Strategic SW - GuruFocus
Harmony Biosciences Reports Strong Q3 2025 Results - TipRanks
Harmony Biosciences Q3 Earnings Call Highlights Robust Growth - TipRanks
Can Harmony Biosciences Holdings Inc. stock continue upward trendEarnings Performance Report & Growth Oriented Trading Recommendations - fcp.pa.gov.br
Harmony Biosciences Raises Forecast After Strong Quarter - Finimize
Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings Miss Estimates - sharewise.com
Harmony Biosciences Q3 2025 Earnings: EPS of $0.87 Beats Estimat - GuruFocus
Harmony Biosciences (HRMY) Exceeds Q3 Revenue Expectations - GuruFocus
Harmony Biosciences (HRMY) Reaffirms 2025 Revenue Projections - GuruFocus
Harmony Biosciences' Q3 Adjusted Net Income, Revenue Rise; Full-Year 2025 Revenue Guidance Raised - MarketScreener
Harmony Biosciences Holdings, Inc. SEC 10-Q Report - TradingView
Earnings Flash (HRMY) Harmony Biosciences Holdings, Inc. Reports Q3 Revenue $239.5M, vs. FactSet Est of $226.9M - MarketScreener
Earnings Flash (HRMY) Harmony Biosciences Holdings, Inc. Posts Q3 Adjusted EPS $1.08 per Share - MarketScreener
Harmony Biosciences shares rise 2% on strong Q3 earnings beat By Investing.com - Investing.com Philippines
Harmony Biosciences Holdings Inc Stock (HRMY) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):